Commitments and Contingencies	6 Months Ended
Aug. 31, 2026
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Note 8 - Commitments and Contingencies Legal Matters We are involved in various legal claims and proceedings in the normal course of operations. We believe the outcome of these matters will not have a material adverse effect on our consolidated financial position, results of operations or liquidity, except as described below. On June 7, 2021, we completed the sale of our North America personal care business to HRB Brands LLC (“HRB Brands”). After the sale, we were named as a defendant in multiple lawsuits related to the use of personal care products previously containing talcum powder, primarily Brut deodorant and Ammens powder sold by our wholly-owned subsidiary, Idelle Labs, Ltd. We tendered indemnification of these cases to HRB Brands, which assumed control of the defense of the claims. After many years, during the fourth quarter of fiscal 2026, HRB Brands asserted that it was contesting the indemnification of these cases and tendered the indemnification back to us. Consequently, in order to protect the Company and its rights and defenses, we began to defend these cases. The Company maintains its position that HRB Brands is obligated to defend and indemnify the Company against these claims and plans to vigorously contest HRB Brands’ position. With respect to the talcum powder cases, we believe we have substantial defenses to the claims. The ultimate outcome of enforcing our indemnification claims against HRB Brands and the litigation relating to the talcum cases is inherently uncertain, and we cannot predict its resolution. During the three and six months ended August 31, 2026, we accrued $4.0 million and $5.3 million, respectively, for potential settlements and legal fees and paid approximately $1.4 million during fiscal 2027 related to these cases. As of August 31, 2026, we had an estimated liability of approximately $5.4 million. We cannot estimate the amount or range of amounts by which the liability may exceed the accrual established because of (i) the inherent difficulty in projecting the number of claims that have not yet been asserted or the time period in which future claims may be asserted, (ii) the complaints nearly always assert claims against multiple defendants where the damages alleged are typically not attributed to individual defendants so that a defendant’s share of liability may turn on the law of joint and several liability, which can vary by state, and (iii) the many factors, developments and inherent uncertainties involved with litigation that could affect the Company’s estimate of the liability. On June 2, 2026, the Company and certain of its officers were named as defendants in a purported federal securities class action lawsuit filed in the United States District Court for the Western District of Texas. The complaint alleges violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, as amended, and Rule 10b‑5 relating to certain prior disclosures of the Company. The plaintiff seeks to represent a class of shareholders who purchased or otherwise acquired the Company’s common stock between April 24, 2024 and October 8, 2025. The Company believes the allegations asserted in the complaint are without merit and intends to defend them vigorously. At this early stage of the proceedings, the Company is unable to predict the outcome of this matter or reasonably estimate the possible loss or range of loss, if any. Tariff Refunds On March 4, 2026, the U.S. Court of International Trade issued an additional ruling that importers that paid tariffs under International Emergency Economic Powers Act (“IEEPA”) are due refunds and ordered U.S. Customs and Border Protection (“CBP”) to begin the refund process for all importers who were subject to IEEPA duties. During fiscal 2026 and 2027, we paid IEEPA tariffs totaling $80.5 million. On April 20, 2026, CBP launched Phase 1 of a process for submitting IEEPA refund claims, and on June 29, 2026, CBP launched Phase 2 of the IEEPA refund claims process. CBP has established the framework for Phase 3 of the IEEPA refund claims process, and the Company was notified in August 2026 of its eligibility to participate. The Company plans to start filing Phase 3 refund claims after CBP begins accepting submissions. As of August 31, 2026, we collected all our Phase 1 tariff refunds and concluded that our submitted Phase 2 tariff refund claims were probable of being recovered, substantially all of which were approved by CBP prior to August 31, 2026. As a result, during the three and six months ended August 31, 2026, we recognized reductions to “Cost of goods sold” of $26.9 million and $28.7 million, respectively. As of August 31, 2026, our receivable for tariff refunds included within prepaids and other current assets totaled $4.3 million and our reduction to inventory for tariff refunds totaled $0.8 million. During the six months ended August 31, 2026, we collected $25.3 million in tariff refunds. The Company will continue to monitor regulatory guidance regarding the refund process, file additional Phase 2 and Phase 3 claims and recognize additional recoveries when the right to receipt becomes probable. EPA Regulatory Matter During fiscal 2022 and 2023, we were in discussions with the U.S. Environmental Protection Agency (the “EPA”) regarding the compliance of packaging and labeling claims on certain of our products in the air and water filtration and humidification categories within the Beauty & Wellness segment that are sold in the U.S. The EPA did not raise any product quality, safety or performance issues. As a result of these packaging and labeling compliance discussions, we completed the repackaging and relabeling of impacted products during fiscal 2023. On August 25, 2026, we entered into a final administrative settlement with the EPA related to this matter for $4.4 million, which will be paid in the third quarter of fiscal 2027. As a result, the estimated liability we recognized during fiscal 2026 of $4.4 million remained outstanding as of August 31, 2026. For additional information refer to Part I, Item 2., “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” including “EPA Compliance Costs.”

On June 7, 2021, we completed the sale of our North America personal care business to HRB Brands LLC (“HRB Brands”). After the sale, we were named as a defendant in multiple lawsuits related to the use of personal care products previously containing talcum powder, primarily Brut deodorant and Ammens powder sold by our wholly-owned subsidiary, Idelle Labs, Ltd. We tendered indemnification of these cases to HRB Brands, which assumed control of the defense of the claims. After many years, during the fourth quarter of fiscal 2026, HRB Brands asserted that it was contesting the indemnification of these cases and tendered the indemnification back to us. Consequently, in order to protect the Company and its rights and defenses, we began to defend these cases. The Company maintains its position that HRB Brands is obligated to defend and indemnify the Company against these claims and plans to vigorously contest HRB Brands’ position. With respect to the talcum powder cases, we believe we have substantial defenses to the claims. The ultimate outcome of enforcing our indemnification claims against HRB Brands and the litigation relating to the talcum cases is inherently uncertain, and we cannot predict its resolution. During the three and six months ended August 31, 2026, we accrued $4.0 million and $5.3 million, respectively, for potential settlements and legal fees and paid approximately $1.4 million during fiscal 2027 related to these cases. As of August 31, 2026, we had an estimated liability of approximately $5.4 million. We cannot estimate the amount or range of amounts by which the liability may exceed the accrual established because of (i) the inherent difficulty in projecting the number of claims that have not yet been asserted or the time period in which future claims may be asserted, (ii) the complaints nearly always assert claims against multiple defendants where the damages alleged are typically not attributed to individual defendants so that a defendant’s share of liability may turn on the law of joint and several liability, which can vary by state, and (iii) the many factors, developments and inherent uncertainties involved with litigation that could affect the Company’s estimate of the liability.

On June 2, 2026, the Company and certain of its officers were named as defendants in a purported federal securities class action lawsuit filed in the United States District Court for the Western District of Texas. The complaint alleges violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, as amended, and Rule 10b‑5 relating to certain prior disclosures of the Company. The plaintiff seeks to represent a class of shareholders who purchased or otherwise acquired the Company’s common stock between April 24, 2024 and October 8, 2025. The Company believes the allegations asserted in the complaint are without merit and intends to defend them vigorously. At this early stage of the proceedings, the Company is unable to predict the outcome of this matter or reasonably estimate the possible loss or range of loss, if any.

On March 4, 2026, the U.S. Court of International Trade issued an additional ruling that importers that paid tariffs under International Emergency Economic Powers Act (“IEEPA”) are due refunds and ordered U.S. Customs and Border Protection (“CBP”) to begin the refund process for all importers who were subject to IEEPA duties. During fiscal 2026 and 2027, we paid IEEPA tariffs totaling $80.5 million. On April 20, 2026, CBP launched Phase 1 of a process for submitting IEEPA refund claims, and on June 29, 2026, CBP launched Phase 2 of the IEEPA refund claims process. CBP has established the framework for Phase 3 of the IEEPA refund claims process, and the Company was notified in August 2026 of its eligibility to participate. The Company plans to start filing Phase 3 refund claims after CBP begins accepting submissions. As of August 31, 2026, we collected all our Phase 1 tariff refunds and concluded that our submitted Phase 2 tariff refund claims were probable of being recovered, substantially all of which were approved by CBP prior to August 31, 2026. As a result, during the three and six months ended August 31, 2026, we recognized reductions to “Cost of goods sold” of $26.9 million and $28.7 million, respectively. As of August 31, 2026, our receivable for tariff refunds included within prepaids and other current assets totaled $4.3 million and our reduction to inventory for tariff refunds totaled $0.8 million. During the six months ended August 31, 2026, we collected $25.3 million in tariff refunds. The Company will continue to monitor regulatory guidance regarding the refund process, file additional Phase 2 and Phase 3 claims and recognize additional recoveries when the right to receipt becomes probable.

During fiscal 2022 and 2023, we were in discussions with the U.S. Environmental Protection Agency (the “EPA”) regarding the compliance of packaging and labeling claims on certain of our products in the air and water filtration and humidification categories within the Beauty & Wellness segment that are sold in the U.S. The EPA did not raise any product quality, safety or performance issues. As a result of these packaging and labeling compliance discussions, we completed the repackaging and relabeling of impacted products during fiscal 2023. On August 25, 2026, we entered into a final administrative settlement with the EPA related to this matter for $4.4 million, which will be paid in the third quarter of fiscal 2027. As a result, the estimated liability we recognized during fiscal 2026 of $4.4 million remained outstanding as of August 31, 2026. For additional information refer to Part I, Item 2., “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” including “EPA Compliance Costs.”